Effect of Deksmedetomidine and Remifentanil in Extubation Agitation (EA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02104297|
Recruitment Status : Unknown
Verified April 2014 by Reyhan Polat, Diskapi Yildirim Beyazit Education and Research Hospital.
Recruitment status was: Not yet recruiting
First Posted : April 4, 2014
Last Update Posted : April 4, 2014
|Condition or disease||Intervention/treatment||Phase|
|Agitation||Drug: deksmedetomidine Drug: Remifentanil Drug: Saline||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||90 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||The Effect of Deksmedetomidin and Remifentanil Infusion on Extubation Agitation and Recovery Conditions on Nasal Septoplasty Operation|
|Study Start Date :||April 2014|
|Estimated Primary Completion Date :||June 2014|
|Estimated Study Completion Date :||June 2014|
Active Comparator: Deksmedetomidine infusion
To prevent agitation deksmedetomidine infused during operation and at the end of surgery agitation scor measured by Riker sedation agitation scale.
deksmedetomidine infused during operation 0.2 mcg/kg/hour
Other Name: Precedex
Experimental: Remifentanil infusion
To prevent agitation remifentanil infused during operation at the end of surgery agitation scor measured by Riker sedation agitation scale.
Remifentanil infused during operation 0.2 mcg/kg/min
Other Name: Ultiva
Placebo Comparator: Saline infusion
Saline infused during operation and at the end of surgery agitation scor measured by Riker sedation agitation scale.
During operation saline infused equal volüme of deksmedetomidine and remifentanil
- To asses postoperative agitation score by Riker sedation agitation scale [ Time Frame: Postoperative first hour ]
- Yo asses postoperative side effects emesis, vomitting or pain [ Time Frame: Postoperative first hour ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02104297
|Contact: Reyhan Polat, MDfirstname.lastname@example.org|
|Reyhan Polat||Not yet recruiting|
|Ankara, Turkey, 06610|
|Contact: Reyhan Polat, MD +905326734310 email@example.com|
|Principal Investigator: Reyhan Polat, MD|
|Principal Investigator:||Reyhan Polat, MD||Yildirim Beyazit Education and Research Hospita|